Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INGM
2526
Ingram Micro Holding
INGM
$6.59B
| $3.38M | ﹤0.01% |
144,906
+7,444
| +5% | +$162K |
|
2527
Monte Rosa Therapeutics
GLUE
$1.32B
| $3.37M | ﹤0.01% |
204,687
+31,383
| +18% | +$600K |
|
2528
Investar Holding Corp
ISTR
$426M
| $3.36M | ﹤0.01% |
123,244
+87,095
| +241% | +$2.44M |
|
2529
Iovance Biotherapeutics
IOVA
$3.16B
| $3.36M | ﹤0.01% |
956,780
+1,313
| +0.1% | +$4.2K |
|
2530
State Street SPDR S&P 500 ESG ETF
EFIV
$1.04B
| $3.36M | ﹤0.01% |
53,233
+4,006
| +8% | +$265K |
|
2531
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $3.36M | ﹤0.01% |
52,150
+2,192
| +4% | +$145K |
|
2532
AMERISAFE
AMSF
$513M
| $3.35M | ﹤0.01% |
100,442
-4,171
| -4% | -$150K |
|
2533
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $3.35M | ﹤0.01% |
128,641
+1,680
| +1% | +$43.9K |
|
2534
Energy Transfer Partners
ET
$72.5B
| $3.34M | ﹤0.01% |
172,971
-102,593
| -37% | -$1.88M |
|
2535
ATN International
ATNI
$488M
| $3.34M | ﹤0.01% |
122,634
+1,132
| +0.9% | +$28.8K |
|
2536
Hertz
HTZ
$798M
| $3.33M | ﹤0.01% |
721,509
-23,349
| -3% | -$113K |
|
2537
Live Oak Bancshares
LOB
$2B
| $3.32M | ﹤0.01% |
100,279
-3,262
| -3% | -$120K |
|
2538
Aehr Test Systems
AEHR
$4.37B
| $3.32M | ﹤0.01% |
89,405
-350
| -0.4% | -$11.2K |
|
2539
Capital City Bank Group
CCBG
$898M
| $3.31M | ﹤0.01% |
76,112
-1,059
| -1% | -$45.5K |
|
2540
Teladoc Health
TDOC
$1.24B
| $3.3M | ﹤0.01% |
604,639
-16,714
| -3% | -$93.8K |
|
2541
Equity Bancshares
EQBK
$1.06B
| $3.29M | ﹤0.01% |
74,169
+1,831
| +3% | +$83.3K |
|
2542
EyePoint Inc
EYPT
$1.27B
| $3.29M | ﹤0.01% |
255,381
-1,362
| -0.5% | -$20.4K |
|
2543
IAMGOLD
IAG
$10.4B
| $3.28M | ﹤0.01% |
174,431
+6,874
| +4% | +$136K |
|
2544
Haverty Furniture Companies
HVT
$449M
| $3.28M | ﹤0.01% |
154,971
+8,586
| +6% | +$209K |
|
2545
Johnson Outdoors
JOUT
$505M
| $3.28M | ﹤0.01% |
70,571
+9,894
| +16% | +$461K |
|
2546
Tecnoglass Holdings
TGLS
$1.86B
| $3.28M | ﹤0.01% |
73,522
+3,880
| +6% | +$187K |
|
2547
First Trust Managed Futures Strategy Fund
FMF
$259M
| $3.27M | ﹤0.01% |
64,681
-4,647
| -7% | -$229K |
|
|
VSDM
2548
Vanguard Short Duration Tax-Exempt Bond ETF
VSDM
$837M
| $3.26M | ﹤0.01% |
+42,748
| New | +$3.29M |
|
2549
Driven Brands
DRVN
$2.13B
| $3.25M | ﹤0.01% |
258,033
-8,819
| -3% | -$124K |
|
2550
HBT Financial
HBT
$1.35B
| $3.25M | ﹤0.01% |
121,651
-1,435
| -1% | -$39.1K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.